The Shareholders' Meeting of Fine Foods & Pharmaceuticals, an Italian CDMO listed on Euronext STAR Milan, approved the 2024 financial statements, which closed with a net profit of over 12 million euros. The entire amount will be allocated to the extraordinary reserve, confirming the prudent approach aimed at capital strengthening.
It was also decided to distribute a dividend of 0,14 euros per share, up 16,7% compared to 2023. The total amount, equal to a maximum of 3,8 million euros, will be taken from the merger surplus reserve and will be paid on 30 April 2025. The coupon detachment is scheduled for 28 April, with a record date set for 29 April.
The Assembly also approved the Remuneration Policy, both in its first section - which describes principles and objectives - and in the second, relating to the compensation actually paid. Finally, the proposal to renew the authorization to purchase and dispose of treasury shares was approved: the duration for purchases will be 18 months, while there are no time limits for sales. Fine Foods, a benefit corporation with a strong vocation for sustainability, also presented the ESG Consolidated Reporting included in the financial statements, in line with the new Legislative Decree 125/2024.
